Compound Detail
CHEMBL2028019
CARIPRAZINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2028019 |
| Name | CARIPRAZINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | KPWSJANDNDDRMB-QAQDUYKDSA-N |
| Therapeutic | ✓ Yes |
14
Targets
86
Activities
3
Assay Types
4
PK Parameters
20
Publications
7
Known Names
8
Indications
Molecular Properties
427.4
MW (Da)
4.34
ALogP
3
HBA
1
HBD
38.8
PSA (Ų)
0.76
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2015 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Psychotic Disorders Bipolar Disorder Bipolar Disorder Child Development Disorders, Pervasive Depressive Disorder Depressive Disorder, Major Schizophrenia Anxiety Disorders
ATC Classification
N05AX15
cariprazine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Drug Warnings
Black Box Warning
General Warning
Activity Summary
Ki 59 meas. best 10.07
EC50 22 meas. best 9.74
IC50 5 meas. best 8.78
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(3) dopamine receptor CHEMBL234 | Ki | 10.07 | 9.7967 | 0.1 | 9 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 9.82 | 9.82 | 0.2 | 1 |
| D(2) dopamine receptor CHEMBL217 | EC50 | 9.74 | 8.7494 | 0.2 | 16 |
| D(2) dopamine receptor CHEMBL217 | Ki | 9.39 | 9.09 | 0.4 | 14 |
| Unchecked CHEMBL612545 | Ki | 9.31 | 8.5933 | 0.5 | 3 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 8.78 | 8.775 | 1.7 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.74 | 8.5343 | 1.8 | 7 |
| D(3) dopamine receptor CHEMBL234 | EC50 | 8.72 | 8.48 | 1.9 | 4 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 8.7 | 8.7 | 2.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 8.51 | 8.51 | 3.1 | 2 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 7.73 | 7.2488 | 18.8 | 8 |
| Histamine H1 receptor CHEMBL231 | Ki | 7.63 | 7.63 | 23.2 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 6.96 | 6.628 | 110.0 | 5 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 6.96 | 6.96 | 111.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.81 | 6.81 | 155.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.7 | 6.6867 | 198.2 | 3 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 5.68 | 5.568 | 2100.0 | 5 |
| D(1B) dopamine receptor CHEMBL1850 | Ki | 5.1 | 5.1 | 7900.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.68 | 4.68 | 20720.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.02333 | hr | Homo sapiens |
| T1/2 | 48.0 | hr | Homo sapiens |
| T1/2 | 0.3723 | hr | Mus musculus |
| T1/2 | 0.5448 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine